MergerLinks Header Logo

Announced

Shin Nippon Biomedical Laboratories to acquire Ina Research for $21m.

Synopsis

Shin Nippon Biomedical Laboratories, a Japan-based company mainly engaged in the provision of clinical trials and drug development services for pharmaceutical companies, agreed to acquire Ina Research, a Japan-based company mainly engaged in the contract testing and environmental business, for $21m.

Principals

Ina Research

target

Ina Research

Shin Nippon Biomed Lab

bidder

Shin Nippon Biomed Lab

Show Details & Financials

Market Context

Sort

Shinji Nitanda

Shinji Nitanda

ManagerCFO at SHIN NIPPON BIOMED LAB
Deal Bio
Total Deals
2/
Total Value
£197M
Ryoichi Nagata

Ryoichi Nagata

ManagerCEO at SHIN NIPPON BIOMED LAB
Deal Bio
Total Deals
2/
Total Value
£197M
Kentaro Matsuzaki

Kentaro Matsuzaki

ManagerBoard Member at INA RESEARCH INC
Deal Bio
Total Deals
1/
Total Value
£20M
Yoshikazu Ashibe

Yoshikazu Ashibe

ManagerIndependent Outside Director at INA RESEARCH INC
Deal Bio
Total Deals
1/
Total Value
£20M
Hisako Sato

Hisako Sato

ManagerIndependent Outside Director at INA RESEARCH INC
Deal Bio
Total Deals
1/
Total Value
£20M
Masatoshi Urano

Masatoshi Urano

ManagerSupervisory board member at INA RESEARCH INC
Deal Bio
Total Deals
1/
Total Value
£20M

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required
Register nowSign up with LinkedIn

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US